Gene · 1452
Papers2,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical regulation of circadian rhythms through inhibition of casein kinase Iδ and α. | Biochem Biophys Res Commun | 2026 | 42810220 | PubTator, text mining | PubMed |
Midazolam Reduces Metabolic Viability and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells with Selective Transcriptional Modulation of Wnt and Hedgehog Components: A Preliminary In Vitro Study. | Pharmaceuticals (Basel) | 2026 | 42797517 | PubTator, text mining | PubMed |
| Systematic Analysis of MRTFB Phosphoproteomic Datasets Reveals Co-Regulated Kinase Networks and Co-Occurring Phosphosites Associated with the Actin Cytoskeleton Pathway. | Curr Issues Mol Biol | 2026 | 42793267 | PubTator, text mining | PubMed |
| Lenalidomide Exposure and TP53-Mutated Myelodysplastic Syndromes/Neoplasms. | Curr Oncol | 2026 | 42782853 | PubTator, text mining | PubMed |
| Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms. | Leukemia | 2026 | 42693162 | PubTator, text mining | PubMed |
| Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival. | Cancer Diagn Progn | 2026 | 42682938 | PubTator, text mining | PubMed |
| CCT8 associates with the MYO10 motor domain and regulates filopodia and breast cancer cell invasion. | J Cell Sci | 2026 | 42677351 | PubTator, text mining | PubMed |
| Discovery of molecular glue degrader for treatment of IMiDs-resistant multiple myeloma based on GLUT-mediated tumor targeting strategy. | Bioorg Chem | 2026 | 42561560 | PubTator, text mining | PubMed |
| The kinase CK1α coordinates the initiation and termination of the cGAS-STING pathway. | Cell Death Differ | 2026 | 42557374 | PubTator, text mining | PubMed |
| A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells. | Cancer Res | 2026 | 42545171 | PubTator, text mining | PubMed |
| Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models. | J Clin Invest | 2026 | 42518285 | PubTator, text mining | PubMed |
| IL-18 Promotes the Development of Lupus Nephritis by Activating the Wnt/β-Catenin Signaling Pathway in Renal Tubular Epithelial Cells. | Inflammation | 2026 | 42448943 | PubTator, text mining | PubMed |
| Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas. | Clin Exp Med | 2026 | 42257744 | PubTator, text mining | PubMed |
| Geraniol Exerts Cytotoxic Effects in Red Cells Through Ca2+ Elevation and Membrane Hyperpolarization: Attenuating Effects of COX/CK1α/Rac1 GTPase Inhibition. | Molecules | 2026 | 42197180 | PubTator, text mining | PubMed |
| FGFR1 but not S6K1/2 drives intrinsic BRAF inhibitor resistance in melanoma. | Cell Death Discov | 2026 | 42151121 | PubTator, text mining | PubMed |
| A Scalable, Direct-to-Biology Platform for Accelerated Discovery of Cereblon-Based Molecular Glue Degraders. | Angew Chem Int Ed Engl | 2026 | 42149616 | PubTator, text mining | PubMed |
| The Case for Kinases: A Phosphorylation Driven Model for Circadian Temperature Compensation. | bioRxiv | 2026 | 42146580 | PubTator, text mining | PubMed |
| CK1α agonists attenuate medulloblastoma stemness and relapse risk. | Cell Death Dis | 2026 | 42031704 | PubTator, text mining | PubMed |
| Casein kinase 1α inhibition reduces prostate cancer cells viability: Role of the autophagy mechanism. | Urol Oncol | 2026 | 41986173 | PubTator, text mining | PubMed |
| The Contribution of Native Protein Complexes to Targeted Protein Degradation. | ACS Chem Biol | 2026 | 41955445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1452/papers